Your browser doesn't support javascript.
loading
Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
Bliss, L; Fine, P. E; Gruer, P. J; Jenkins, P. A; Liomba, N. G; Lucas, S. B; Msosa, E; Ponnighaus, J. M; Sterne, J. A; Wilson, R. J.
  • Bliss, L; s.af
  • Fine, P. E; s.af
  • Gruer, P. J; s.af
  • Jenkins, P. A; s.af
  • Liomba, N. G; s.af
  • Lucas, S. B; s.af
  • Msosa, E; s.af
  • Ponnighaus, J. M; s.af
  • Sterne, J. A; s.af
  • Wilson, R. J; s.af
Lancet ; : 636-39, 1992.
Article in English | AIM | ID: biblio-1264824
ABSTRACT
Protection afforded BCG vaccines against tuberculosis and leprosy varies widely between different populations. In the only controlled trial which assessed protective efficacy of BCG (Danish and Pasteur strains) against both diseases; there was slightly more protection against leprosy than against tuberculosis. Protection was estimated at 50 percent or greater against leprosy; and there was no evidence for lower protection against multibacillary than against paucibacillary disease. There was no statistically significant protection by BCG against tuberculosis in this population
Subject(s)
Search on Google
Index: AIM (Africa) Main subject: Tuberculosis / BCG Vaccine / Vaccination / Leprosy Language: English Journal: Lancet Year: 1992 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: AIM (Africa) Main subject: Tuberculosis / BCG Vaccine / Vaccination / Leprosy Language: English Journal: Lancet Year: 1992 Type: Article